Department of Otolaryngology-Head and Neck Surgery, Shandong Provincial ENT Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
State Key Laboratory of Bioelectronics, School of Life Sciences and Technology, Jiangsu Province High-Tech Key Laboratory for Bio-Medical Research, Southeast University, Nanjing, China.
Autophagy. 2021 Dec;17(12):4159-4181. doi: 10.1080/15548627.2021.1905466. Epub 2021 Apr 12.
Spiral ganglion neurons (SGNs) are auditory neurons that relay sound signals from the inner ear to the brainstem. The ototoxic drug cisplatin can damage SGNs and thus lead to sensorineural hearing loss (SNHL), and there are currently no methods for preventing or treating this. Macroautophagy/autophagy plays a critical role in SGN development, but the effect of autophagy on cisplatin-induced SGN injury is unclear. Here, we first found that autophagic flux was activated in SGNs after cisplatin damage. The SGN apoptosis and related hearing loss induced by cisplatin were alleviated after co-treatment with the autophagy activator rapamycin, whereas these were exacerbated by the autophagy inhibitor 3-methyladenine, indicating that instead of inducing SGN death, autophagy played a neuroprotective role in SGNs treated with cisplatin both and . We further demonstrated that autophagy attenuated reactive oxygen species (ROS) accumulation and alleviated cisplatin-induced oxidative stress in SGNs to mediate its protective effects. Notably, the role of the antioxidant enzyme PRDX1 (peroxiredoxin 1) in modulating autophagy in SGNs was first identified. Deficiency in PRDX1 suppressed autophagy and increased SGN loss after cisplatin exposure, while upregulating PRDX1 pharmacologically or by adeno-associated virus activated autophagy and thus inhibited ROS accumulation and apoptosis and attenuated SGN loss induced by cisplatin. Finally, we showed that the underlying mechanism through which PRDX1 triggers autophagy in SGNs was, at least partially, through activation of the PTEN-AKT signaling pathway. These findings suggest potential therapeutic targets for the amelioration of drug-induced SNHL through autophagy activation.: 3-MA: 3-methyladenine; AAV : adeno-associated virus; ABR: auditory brainstem responses; AKT/protein kinase B: thymoma viral proto-oncogene; Baf: bafilomycin A; CAP: compound action potential; COX4I1: cytochrome c oxidase subunit 4I1; Cys: cysteine; ER: endoplasmic reticulum; HO: hydrogen peroxide; HC: hair cell; MAP1LC3B/LC3B: microtubule-associated protein 1 light chain 3 beta; NAC: N-acetylcysteine; PRDX1: peroxiredoxin 1; PTEN: phosphatase and tensin homolog; RAP: rapamycin; ROS: reactive oxygen species; SGNs: spiral ganglion neurons; SNHL: sensorineural hearing loss; SQSTM1/p62: sequestosome 1; TOMM20: translocase of outer mitochondrial membrane 20; TUNEL: terminal deoxynucleotidyl transferase-mediated dUTP nick-end-labeling; WT: wild type.
螺旋神经节神经元(SGNs)是将内耳的声音信号传递到脑干的听觉神经元。耳毒性药物顺铂可损伤 SGNs,从而导致感音神经性听力损失(SNHL),目前尚无预防或治疗方法。巨自噬/自噬在 SGN 发育中起关键作用,但自噬对顺铂诱导的 SGN 损伤的影响尚不清楚。在这里,我们首先发现顺铂损伤后 SGN 中的自噬流被激活。与自噬抑制剂 3-甲基腺嘌呤相比,自噬激活剂雷帕霉素共同处理可减轻顺铂诱导的 SGN 凋亡和相关听力损失,而自噬抑制剂则加剧了顺铂诱导的 SGN 凋亡和相关听力损失,这表明自噬在顺铂处理的 SGN 中发挥了神经保护作用,而不是诱导 SGN 死亡。我们进一步证明,自噬减轻了活性氧(ROS)的积累,并减轻了 SGN 中的顺铂诱导的氧化应激,从而介导其保护作用。值得注意的是,首次确定了抗氧化酶 PRDX1(过氧化物酶 1)在调节 SGN 中自噬的作用。PRDX1 缺陷抑制自噬并增加顺铂暴露后的 SGN 损失,而药理学上调 PRDX1 或通过腺相关病毒激活自噬可抑制 ROS 积累和凋亡,并减轻顺铂诱导的 SGN 损失。最后,我们表明,PRDX1 在 SGN 中触发自噬的潜在机制至少部分是通过激活 PTEN-AKT 信号通路。这些发现为通过自噬激活改善药物诱导的 SNHL 提供了潜在的治疗靶点。